CD4


Journal

Immunity, inflammation and disease
ISSN: 2050-4527
Titre abrégé: Immun Inflamm Dis
Pays: England
ID NLM: 101635460

Informations de publication

Date de publication:
Nov 2022
Historique:
revised: 01 10 2022
received: 16 08 2022
accepted: 04 10 2022
pubmed: 28 10 2022
medline: 1 11 2022
entrez: 27 10 2022
Statut: ppublish

Résumé

Chlamydia pneumoniae (C. pneumoniae) is a gram-negative intracellular bacterium that causes respiratory infection in humans, including subjects with or without asthma. C. pneumoniae activates cells (e.g., monocytes/macrophages) in vitro, and produces cytokines that may contribute to inflammatory responses observed in asthma. Immunological differences exist between subjects with or without asthma, with regard to host responses to C. pneumoniae. The heterogeneity and subsequent diverse pathophysiology of asthma can be better understood by analyzing the repertoire of T-cell subpopulations; the most common distinction between different asthma endotypes includes cytokines produced by CD4

Identifiants

pubmed: 36301027
doi: 10.1002/iid3.726
pmc: PMC9609443
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e726

Informations de copyright

© 2022 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.

Références

Expert Opin Pharmacother. 2015 Feb;16(2):205-12
pubmed: 25579069
Arch Pediatr Adolesc Med. 1994 Jul;148(7):727-32
pubmed: 8019629
Hum Immunol. 2016 May;77(5):382-8
pubmed: 26924667
J Immunol. 2018 Jul 1;201(1):87-97
pubmed: 29752315
Am J Respir Crit Care Med. 2005 Nov 1;172(9):1078-89
pubmed: 15961690
J Allergy Clin Immunol. 2001 Apr;107(4):595-601
pubmed: 11295645
Scand J Immunol. 2017 Jul;86(1):59-64
pubmed: 28480606
Eur Ann Allergy Clin Immunol. 2021 Sep;53(5):201-208
pubmed: 33182992
Immunol Rev. 2006 Jun;211:236-54
pubmed: 16824132
J Immunol. 2004 Feb 15;172(4):2407-15
pubmed: 14764711
Clin Vaccine Immunol. 2010 May;17(5):705-12
pubmed: 20219874
Clin Infect Dis. 1992 Jan;14(1):178-82
pubmed: 1571425
Immun Inflamm Dis. 2022 Nov;10(11):e726
pubmed: 36301027
J Blood Med. 2021 May 31;12:385-394
pubmed: 34104025

Auteurs

Tamar A Smith-Norowitz (TA)

Department of Pediatrics, Division of Infectious Diseases, State University of New York Downstate Health Sciences University, Brooklyn, New York, USA.

Sarah Shidid (S)

Department of Pediatrics, Division of Infectious Diseases, State University of New York Downstate Health Sciences University, Brooklyn, New York, USA.

Yitzchok M Norowitz (YM)

Department of Pediatrics, Division of Infectious Diseases, State University of New York Downstate Health Sciences University, Brooklyn, New York, USA.

Stephan Kohlhoff (S)

Department of Pediatrics, Division of Infectious Diseases, State University of New York Downstate Health Sciences University, Brooklyn, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH